TRIBUNNEWS.COM - Masih ingat kabar viral soal Si Zombie Angelina Jolie?
Ya, Sahar Tabar (20), seorang wanita asal Iran, sempat viral di Instagram setelah memposting wajah Angelina Jolie ala zombie.
Tabar, menggunakan teknik make up dan editing foto, sehingga membuat wajahnya begitu mirip Angelina Jolie versi zombie yang menyeramkan.
Saking sempurnanya teknik tata rias dari Tabar, munculnya foto zombie ini bahkan sempat memunculkan kabar hoax.
Beredar kabar bahwa Tabar rela melakukan 50 kali operasi plastik mahal dan diet ekstrem, demi membuat wajahnya mirip Angelina Jolie.
Padahal, Tabar telah mengonfirmasi, bahwa wajah itu hanyalah rekaan dari teknik tata rias, dibumbui editing foto digital.
Meski demikian, Tabar mengakui kalau ia melakukan sedikit operasi plastik, yakni di bagian hidung dan bibir.
Nah, setelah membuat gaduh media sosial, Tabar akhirnya menunjukkan wajah aslinya ke media sosial.
Dilansir The Daily Mail 24 Juli 2018, Tabar mengunggah 2 wajah aslinya.
Tanpa make up dan editing foto, wajah asli Tabar begitu berbeda dengan Si Zombie Angelina Jolie.
Hanya Make Up
Dalam wawancara dengan media Rusia, Sputnik, Sahar Tabar mengaku heran mendengar kabar hoax bahwa dia melakukan operasi plastik demi ambisi meniru wajah Angelina Jolie
"Aku bahkan tidak mengidolakan Jolie," ujar Sahar Tabar.
"Semua ini hanyalah photoshop dan make up. Setiap kali aku mengunggah foto, aku melukis wajahku untuk kesenangan belaka,"
"Ini semua hanya ekspresi seni. Fansku tahu kalau itu bukan wajah asliku," ujar Sahar Tabar. (*)
Needle therapy can diminish joint torment caused by drugs called aromatase inhibitors, as indicated by comes about because of a vast, thorough investigation of this approach in postmenopausal ladies with beginning time bosom malignancy.
Numerous ladies with hormone receptor (HR)– positive early bosom diseases, which depend on estrogen to fuel tumor development, take aromatase inhibitors after medical procedure to diminish their danger of the malignancy repeating. These medications, which square estrogen generation, are additionally used to avert bosom malignancy in postmenopausal ladies at high hazard for the malady and to treat HR-positive metastatic bosom tumor.
"Around half of patients on these pharmaceuticals whine of some joint agony or solidness, and about portion of those patients portray the torment as extreme," making a few ladies quit taking the medications, said the preliminary's lead agent, Dawn Hershman, M.D., of Columbia University Medical Center.
A few little investigations have recommended that needle therapy may lighten aromatase inhibitor– related joint agony and solidness, in spite of the fact that others have demonstrated no advantage, said Dr. Hershman, who introduced the discoveries of the new examination December 7 at the San Antonio Breast Cancer Symposium. She and her partners planned their huge examination to find a clearer solution to the topic of whether needle therapy can mitigate aromatase inhibitor– related agony.
"Recognizing mediations to address aromatase inhibitor– actuated joint agony is fundamental however has been missing to date. This preliminary exhibited that, contrasted and fake treatment, needle therapy may give a solid, nonpharmacologic choice for enhancing the musculoskeletal manifestations experienced by these patients," said Raquel Reinbolt, M.D., a restorative oncologist having some expertise in bosom malignancy with The Ohio State University Comprehensive Cancer Center, who was not included with the investigation.
"Lessening the medication harmfulness experience may then convert into enhanced adherence [to therapy], and eventually, enhanced bosom malignancy results," Dr. Reinbolt said.
What's more, having needle therapy, alongside connecting with the acupuncturist, as an option or notwithstanding taking medicine torment pharmaceuticals may enable patients to feel engaged to oversee joint torment that can happen as a reaction of their growth treatment, said Ann O'Mara, Ph.D., R.N., head of palliative care explore in NCI's Division of Cancer Prevention.
A noteworthy quality of the examination is that it was a multisite preliminary and included numerous patients from general oncology hones, not simply from college restorative focuses, Dr. O'Mara noted. This implies the outcomes are probably going to be extensively generalizable to ladies in the network.
Relief from discomfort Continued after Treatments Ended
The clinical preliminary was driven by the NCI-financed SWOG clinical preliminaries gathering and did at 11 destinations that partake in the NCI Community Oncology Research Program (NCORP). The 226 ladies in the preliminary were all taking a third-age aromatase inhibitor—anastrozole (Arimidex®), letrozole (Femara®), or exemestane (Aromasin®)— after medical procedure for beginning period HR-positive bosom disease and were haphazardly doled out to get genuine needle therapy, sham needle therapy (fake treatment), or no treatment.
Sham needle therapy includes shallow inclusion of short, thin needles at non-needle therapy focuses.
All acupuncturists engaged with the investigation were authorized and were thoroughly prepared nearby by an acupuncturist on the examination group. They were checked for nature of care all through the investigation.
To be enlisted in the examination, ladies couldn't have taken opioid or corticosteroid sedates or got any option or exercise based recuperation for AI-related joint torment in the previous a month. Quite, Dr. Hershman stated, 80% of the patients in the examination were assuming control over-the-counter acetaminophen or ibuprofen for joint agony without encountering help.
Generally 50% of the examination members (110) got genuine needle therapy two times every week for a month and a half, trailed by once seven days support sessions for 6 more weeks. The other half were in one of two control gatherings: 59 got sham needle therapy on an indistinguishable timetable from the genuine needle therapy gathering, and the rest of the 57 got no treatment.
The no-treatment amass was incorporated to control for any conceivable advantages or conceivable negative impacts of the sham needle therapy, Dr. Hershman clarified.
Study examiners took after the ladies for an additional 12 weeks after medicines finished. Patients provided details regarding their agony previously, amid, and after treatment utilizing different techniques, including a poll on which ladies could demonstrate a rating of "most exceedingly bad torment" on a size of 0 to 10.
Following a month and a half, "we saw a mean two-point decrease of most exceedingly terrible torment [in the genuine needle therapy aggregate contrasted and most exceedingly terrible agony before treatment], which is a noteworthy lessening," and these impacts were kept up following 12 weeks, Dr. Hershman said.
Additionally, "even at 24 weeks, ladies in the genuine needle therapy gather had less agony by and large than ladies in either [control] gathering," Dr. Hershman included.
The principle reaction of genuine and sham needle therapy was mellow wounding, which was more typical in the genuine needle therapy amass than in the sham-needle therapy gathering.
Patients in both the sham-needle therapy and no-treatment bunches announced an around one-point mean diminishment in most exceedingly awful torment at a month and a half. In spite of the fact that it's not clear why the control bunches additionally observed a change, Dr. Hershman said that, in manifestation administration ponders where patients are checked and surveyed after some time, scientists frequently observe a change of indications in the control gathering.
More Investigations Planned
The new discoveries should influence wellbeing to mind suppliers more inclined to recommend needle therapy to their patients, Dr. Hershman said.
"Needle therapy is a protected and viable elective approach for overseeing aromatase inhibitor– actuated joint agony. The essential confinements of this treatment at the present time are cost and accessibility. Ideally, this [new] information will produce extra dialog in regards to repayment [by therapeutic insurance] and access to treatment," Dr. Reinbolt said.
One conceivable impediment of the investigation, Dr. O'Mara stated, is that most members (88%) were white, regardless of the incorporation of patients from over the United States. Just 5% and 7% of members, separately, were dark or Asian.
Of course, a few inquiries remain. "In the event that you begin having a throbbing painfulness, would it be advisable for you to return [for more needle therapy sessions]? Should you proceed with, say, once seven days medicines until the point that you complete the process of taking aromatase inhibitors?" Dr. O'Mara inquired.
The group isn't wanting to seek after those inquiries. Yet, Dr. Hershman stated, "We offered everyone 10 needle therapy sessions toward the finish of 24 weeks, paying little heed to which assemble they were in, and we'll be completing a different investigation to perceive what number of patients in each gathering acknowledged the offer."
The group additionally plans to utilize tissue tests that they gathered from patients all through the preliminary to pick up a superior comprehension of what causes aromatase inhibitor– related joint indications, "and what the instrument of needle therapy might be regarding giving help with discomfort," Dr. Hershman said.